| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/04/2009 | EP2029603A1 Pyrrolo[3,2-d]pyrimidin-4-one derivative as myeloperoxidase inhibitor |
| 03/04/2009 | EP2029598A1 2-thioxanthine derivatives acting as mpo-inhibitors |
| 03/04/2009 | EP2029596A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
| 03/04/2009 | EP2029591A1 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof |
| 03/04/2009 | EP2029579A2 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 03/04/2009 | EP2029560A2 1,3-oxazolidin-2-one derivatives useeful as cetp inhibitors |
| 03/04/2009 | EP2029542A2 Primary amines as renin inhibitors |
| 03/04/2009 | EP2029539A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 03/04/2009 | EP2029535A1 Isoindole derivatives useful for treating pain, gastrointestinal diseases and cancer |
| 03/04/2009 | EP2029145A2 Pyrrolopyrimidine compounds and their uses |
| 03/04/2009 | EP2029143A2 Substituted 8-[6-amino-3-pyridyl]xanthines |
| 03/04/2009 | EP2029138A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| 03/04/2009 | EP2029137A2 Antihypertensive therapy method |
| 03/04/2009 | EP2029099A2 Combination antihypertensive wafer |
| 03/04/2009 | EP1833795B1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 03/04/2009 | EP1695983B1 Glucagon-like peptide-1 analogs |
| 03/04/2009 | EP1635816B1 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases |
| 03/04/2009 | EP1519957B1 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 03/04/2009 | EP1515984B1 Peptide derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 03/04/2009 | EP1506951B1 Method for the preparation of total salvianolic acid |
| 03/04/2009 | EP1490071B1 Therapeutic uses of sapogenins |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
| 03/04/2009 | EP1455785B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 03/04/2009 | EP1427720B1 3-substituted-4-pyrimidone derivatives |
| 03/04/2009 | EP1408931B1 Isotonic lipid emulsions |
| 03/04/2009 | EP1401863B1 Somatostatin-dopamine chimeric analogs |
| 03/04/2009 | EP1230243B1 Poycyloalkylpurines as adenosine receptor antagonists |
| 03/04/2009 | EP1140908B1 Triazole compounds with dopamine-d3-receptor affinity |
| 03/04/2009 | EP1088062B1 Transplants for myocardial scars |
| 03/04/2009 | CN201200625Y Hemorrhoid suppository |
| 03/04/2009 | CN201200505Y Intravascular stent for treating coronary heart disease |
| 03/04/2009 | CN101379396A Method for detecting a biomarker of oxidative stress in a biological sample |
| 03/04/2009 | CN101379048A Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
| 03/04/2009 | CN101379033A Secondary amines |
| 03/04/2009 | CN101378763A Trialkylsilylbenzylaminocarboxyindoles, indazoles and indolines and their use in treating CETP-mediated disorders |
| 03/04/2009 | CN101378762A A method of treating an acute vascular disorder |
| 03/04/2009 | CN101376660A 7-benzyl-3-sulfur-7-azabicyclo[3,3,1] nonacoane , preparation and salts thereof, and use of the salts |
| 03/04/2009 | CN101376648A Cinepazide maleate crystal form and preparation thereof |
| 03/04/2009 | CN101376022A Medicament composition containing defibrase modified by PEG |
| 03/04/2009 | CN101376007A Powder for cleaning anus and intestines |
| 03/04/2009 | CN101375990A Composition for treating cardiovascular disease and preparation thereof |
| 03/04/2009 | CN101375979A Fragrant pollen medicine for inducing resuscitation |
| 03/04/2009 | CN101375964A External-use medicament for treating anorectal diseases and formulating method |
| 03/04/2009 | CN101375963A Vagina-cleaning lotion and preparation method |
| 03/04/2009 | CN101375962A Formulation for activating blood and freeing collateral vessels and preparation method thereof |
| 03/04/2009 | CN101375952A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
| 03/04/2009 | CN101375932A Chinese medical ointment for treating recurrent hemorrhoid |
| 03/04/2009 | CN101375870A Compound creat injection and preparation method |
| 03/04/2009 | CN101375869A Slow/controlled release pellet composition containing ginkgo leaf extracts and preparation method thereof |
| 03/04/2009 | CN101375857A Application of yew polysaccharide in preparing medicament for myocardial ischemia-reperfusion injury |
| 03/04/2009 | CN101375853A Hemorrhoid ointment and preparation method thereof |
| 03/04/2009 | CN101375849A Novel dosage form of sinomenine medicament or hydrochlorate thereof and preparation technique thereof |
| 03/04/2009 | CN101375714A Pollen salt |
| 03/04/2009 | CN100465186C A composition and a method for inhibiting platelet aggregation |
| 03/04/2009 | CN100464766C A medicinal composition for treating acute and chronic congestive heart failures and a preparation method thereof |
| 03/04/2009 | CN100464757C A method for preparing hirudin by using leech bloodsuckers as the raw material |
| 03/04/2009 | CN100464747C A medicine composition with bailobalide |
| 03/04/2009 | CN100464738C A production method of pharmaceutical solid preparation with poorly soluble drugs |
| 03/04/2009 | CN100464639C A composition with heart rate reducing property |
| 03/03/2009 | US7498460 Isophthalic acid derivatives |
| 03/03/2009 | US7498421 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome |
| 03/03/2009 | US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/03/2009 | US7498358 Human ADAM-10 inhibitors |
| 03/03/2009 | US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect |
| 03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
| 03/03/2009 | US7498330 4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds |
| 03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
| 03/03/2009 | US7498308 The analogs are resistant to diaminopeptidase IV degradation and bind zinc; are active over an extended time in vivo |
| 03/03/2009 | US7498301 Administering or applying anserine for treating muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, stress and myocardial infarction optionally with a diuretic |
| 03/03/2009 | US7498300 Corticotropin releasing factor peptide for use in the treatment of nervous system and hypertensive disorders |
| 03/03/2009 | US7498147 Modulating the activity of one or more elements in the complement/lipid pathway |
| 03/03/2009 | US7498034 Imaging, diagnosis and treatment of disease |
| 03/03/2009 | CA2420222C Orally administered peptides to ameliorate atherosclerosis |
| 03/03/2009 | CA2410880C 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 03/03/2009 | CA2335551C Thyroid hormone analogues and methods for their preparation |
| 03/03/2009 | CA2280089C Compositions and methods for reducing ocular hypertension |
| 03/03/2009 | CA2270286C Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device |
| 02/26/2009 | WO2009026107A1 Protein kinase inhibitors |
| 02/26/2009 | WO2009025478A1 Indole and indazole compounds as an inhibitor of cellular necrosis |
| 02/26/2009 | WO2009025477A1 Indole compounds as an inhibitor of cellular necrosis |
| 02/26/2009 | WO2009025265A1 Piperazine derivative |
| 02/26/2009 | WO2009024997A1 Stable amorphous form of carvedilol dihydrogen phosphate with stabilizer |
| 02/26/2009 | WO2009024906A1 4-pyrimidinesulfamide derivative |
| 02/26/2009 | WO2009024550A1 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators |
| 02/26/2009 | WO2009023959A1 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 02/26/2009 | WO2008045604A3 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 02/26/2009 | WO2008030579A3 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 02/26/2009 | US20090054502 Benzimidazole Derivative and Use as Angiotensin II Antagonist |
| 02/26/2009 | US20090054500 Composition and methods useful in preventing cardiac hypertrophy |
| 02/26/2009 | US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis |
| 02/26/2009 | US20090054488 Isomigrastatin Analogs In The Treatment Of Cancer |
| 02/26/2009 | US20090054486 Polymorphic form xvi of fexofenadine hydrochloride |
| 02/26/2009 | US20090054484 Substituted heteroaryl benzofuran acids |
| 02/26/2009 | US20090054483 Substituted Quinolines as Inhibitors of Leukotriene Biosynthesis |
| 02/26/2009 | US20090054480 Novel quinuclidine carbamate derivatives and medicinal compositions containing the same |
| 02/26/2009 | US20090054467 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases |
| 02/26/2009 | US20090054459 Substituted indoles |
| 02/26/2009 | US20090054457 Substituted heterocyclic compounds |